APOE and Alzheimer disease: Our findings reveal that CSF lipoproteins from AD patients show reduced efficiency in delivering cholesterol to neurons, with APOE4 emerging as a potential key factor in the disrupted neuronal cholesterol uptake observed in AD pathophysiology.